Integra LifeSciences Holdings Cash Flow-to-Debt Ratio
Integra LifeSciences Holdings cash flow-to-debt ratio. Integra LifeSciences Holdings (IART) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of $9.80 Million could theoretically repay 0% of its total liabilities ($2.54 Billion) in one year. Check Integra LifeSciences Holdings (IART) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Integra LifeSciences Holdings (1995–2025)
Cash flow-to-debt ratio of Integra LifeSciences Holdings from 1995 to 2025. Historical debt coverage capacity for Integra LifeSciences Holdings across 31 annual periods. Check Integra LifeSciences Holdings earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Integra LifeSciences Holdings Cash Flow-to-Debt Ratio by Year (1995–2025)
Integra LifeSciences Holdings cash flow-to-debt ratio by year from 1995 to 2025. Year-by-year debt coverage analysis for Integra LifeSciences Holdings. For the full cash flow conversion analysis, see IART cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | $50.38 Million | $2.56 Billion | ▼ -62.1% |
| 2024 | 0.05x | $129.38 Million | $2.49 Billion | ▼ -18.6% |
| 2023 | 0.06x | $139.96 Million | $2.19 Billion | ▼ -49.7% |
| 2022 | 0.13x | $264.47 Million | $2.09 Billion | ▼ -14.9% |
| 2021 | 0.15x | $312.43 Million | $2.10 Billion | ▲ +53.5% |
| 2020 | 0.10x | $203.83 Million | $2.10 Billion | ▼ -20.9% |
| 2019 | 0.12x | $231.43 Million | $1.89 Billion | ▲ +6.4% |
| 2018 | 0.12x | $199.68 Million | $1.73 Billion | ▲ +126.3% |
| 2017 | 0.05x | $114.54 Million | $2.25 Billion | ▼ -57.6% |
| 2016 | 0.12x | $116.41 Million | $968.29 Million | ▲ +30.2% |
| 2015 | 0.09x | $94.48 Million | $1.02 Billion | ▲ +1.6% |
| 2014 | 0.09x | $79.46 Million | $874.30 Million | ▼ -10.2% |
| 2013 | 0.10x | $53.27 Million | $526.05 Million | ▲ +11.4% |
| 2012 | 0.09x | $58.72 Million | $645.82 Million | ▼ -43.2% |
| 2011 | 0.16x | $104.33 Million | $651.47 Million | ▼ -21.5% |
| 2010 | 0.20x | $105.57 Million | $517.35 Million | ▼ -29.4% |
| 2009 | 0.29x | $143.24 Million | $495.22 Million | ▲ +172.6% |
| 2008 | 0.11x | $72.59 Million | $684.23 Million | ▲ +25.8% |
| 2007 | 0.08x | $47.03 Million | $557.58 Million | ▼ -62.7% |
| 2006 | 0.23x | $71.70 Million | $317.46 Million | ▼ -37.0% |
| 2005 | 0.36x | $56.85 Million | $158.61 Million | ▲ +36.9% |
| 2004 | 0.26x | $38.98 Million | $148.89 Million | ▲ +8.2% |
| 2003 | 0.24x | $34.83 Million | $144.00 Million | ▼ -79.5% |
| 2002 | 1.18x | $31.98 Million | $27.07 Million | ▲ +77.1% |
| 2001 | 0.67x | $15.70 Million | $23.53 Million | ▲ +540.3% |
| 2000 | -0.15x | $-4.96 Million | $32.73 Million | ▼ -271.5% |
| 1999 | 0.09x | $2.50 Million | $28.30 Million | ▲ +103.0% |
| 1998 | -2.97x | $-9.80 Million | $3.30 Million | ▲ +2.3% |
| 1997 | -3.04x | $-7.90 Million | $2.60 Million | ▲ +12.6% |
| 1996 | -3.48x | $-8.00 Million | $2.30 Million | ▼ -24.2% |
| 1995 | -2.80x | $-5.60 Million | $2.00 Million | — |